Prof. Yaron Niv, Director of the Institute of Gastroenterology at Rabin Medical Center, along with his colleague and friend, Dr. C. Richard Boland, Chief of gastroenterology at Baylor University, have identified a virus that exists in 90 percent of colon cancer cases in Israel. This normally harmless virus, called JC, is present in 70 to 80 percent of all human beings. But until now, it was not known what triggers change in the genetic structure of the large intestine that enables the cancer to develop. Prof. Niv and Dr. Boland studied hundreds of Israeli patients with colon cancer, looking at their cancer tissue for DNA sequences of the JC virus in the cancer cells. They found that more than 80 percent of those tested had the DNA for the JC virus. The JC virus - or more specifically the T-antigen protein that is synthesized by the virus - may be the trigger in the development of at least 20-40 percent of the cases of colorectal cancer.
As if being stricken with cancer isn't enough, there are many cancer patients whose immune systems become so weakened by chemotherapy treatments that they become prone to life threatening infections.
Tel Aviv University study has determined that natural, spontaneous deliveries and induced deliveries following the rupture of the amniotic sac in the mother share similar neonatal outcomes, contradicting common wisdom.
A new advanced technology has been developed for the first time worldwide, at Rabin Medical Center's Invasive Cardiology Institute, where all pertinent information collected during the cardiac catheterization procedure is sent directly to an iPad.